Illumina

Illumina, Inc. is an American company that develops, manufactures and markets integrated systems for the analysis of genetic variation and biological function. Using its technologies, the Company provides a line of products and services that serve the sequencing, genotyping and gene expression markets. Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations and biotechnology companies.

Company Growth (employees)
Type
Public
HQ
San Diego, US
Founded
1998
Size (employees)
5,500 (est)
Illumina was founded in 1998 and is headquartered in San Diego, US

Illumina Office Locations

Illumina has offices in San Diego, Madison, San Francisco, Santa Clara and in 11 other locations
San Diego, US (HQ)
5200 Illumina Way
Madison, US
200 5602 Research Park Blvd
Redwood City, US
800 Saginaw Dr
San Francisco, US
210 499 Illinois St
Santa Clara, US
210 451 El Camino Real
Scoresby, AU
1 International Ct
Show all (15)

Illumina Financials and Metrics

Illumina Financials

Illumina's revenue was reported to be $2.4 b in FY, 2017
USD

Revenue (Q2, 2017)

662 m

Gross profit (Q2, 2017)

434 m

Gross profit margin (Q2, 2017), %

66%

Net income (Q2, 2017)

120 m

EBIT (Q2, 2017)

143 m

Market capitalization (22-Dec-2017)

31.9 b

Cash (07-Feb-2017)

1.2 b

EV

31.9 b
Illumina's current market capitalization is $31.9 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

1.4 b1.9 b2.2 b2.4 b2.4 b

Revenue growth, %

31%19%8%

Cost of goods sold

670.5 m731.9 m731.9 m

Gross profit

1.5 b1.7 b1.7 b
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q3, 2016Q1, 2016Q2, 2016Q3, 2017Q1, 2017Q2, 2017

Revenue

356.8 m420.8 m447.6 m480.6 m538.6 m539.4 m550.3 m607.1 m571.8 m600.1 m714 m598 m662 m

Cost of goods sold

146.9 m142.5 m147 m146.7 m163.5 m163 m162.7 m181 m174.7 m176.3 m232 m230 m228 m

Gross profit

209.9 m278.3 m300.5 m333.9 m375 m376.4 m387.5 m426.2 m397.1 m423.8 m482 m368 m434 m

Gross profit Margin, %

59%66%67%69%70%70%70%70%69%71%68%62%66%
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

711.6 m636.2 m768.8 m734.5 m734.5 m

Accounts Receivable

238.9 m289.5 m385.5 m381.3 m381.3 m

Inventories

22.8 m29.8 m54.3 m77.9 m300.2 m

Current Assets

1.6 b1.9 b2.1 b2.3 b2.3 b
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q3, 2016Q1, 2016Q2, 2016Q3, 2017Q1, 2017Q2, 2017

Cash

691.8 m518.5 m675.2 m829.9 m533.5 m591.1 m551.5 m794.7 m754.9 m951.7 m1.4 b981 m1.2 b

Accounts Receivable

235.4 m293 m258.7 m276.7 m350 m368.6 m413.5 m381.6 m402.5 m372.5 m383 m368 m372 m

Inventories

159.9 m164.2 m177.5 m199.3 m205.2 m223.6 m233.8 m312.2 m287.9 m311.4 m327 m299 m309 m

Current Assets

1.5 b1.6 b1.6 b1.9 b2.1 b2.2 b2.2 b2.3 b2.1 b2.1 b2.8 b2.5 b2.6 b
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

125.3 m353.4 m457.4 m428.1 m428.1 m

Depreciation and Amortization

50.8 m61.9 m72.7 m90 m90 m

Accounts Receivable

(16 m)(50 m)(96 m)3.2 m3.2 m

Inventories

1.8 m6.6 m(11 m)(1.2 m)(29.7 m)
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q3, 2016Q1, 2016Q2, 2016Q1, 2017

Net Income

31.4 m60 m46.6 m93.5 m136.7 m102.2 m115.6 m116.9 m87.2 m116.4 m348 m

Accounts Receivable

258.7 m276.7 m350 m368.6 m413.5 m381.6 m402.5 m372.5 m368 m

Inventories

177.5 m199.3 m205.2 m223.6 m233.8 m312.2 m287.9 m311.4 m299 m

Accounts Payable

91.5 m96.1 m106.7 m107.9 m123.4 m134.1 m154.7 m250.7 m142 m
USDY, 2017

EV/EBIT

222.9 x

Revenue/Employee

120.4 k

Financial Leverage

1.8 x
Show all financial metrics

Illumina Market Value History

Illumina Median Salaries

Source: 236 public H-1B filings from Illumina

Illumina's Web-traffic and Trends

Illumina Online and Social Media Presence

Illumina News and Updates

Cancer/Tumor Profiling Global Market Top Key Players – Illumina , QIAGEN , NeoGenomics Laboratories , HTG Molecular Diagnostic , Genomic Health and Forecast to 2022

Wiseguyreports.Com Added New Market Research Report On -“Global Cancer/Tumor Profiling Market 2018 Top Manufacturers, Production , Growth and Future Demand Forecast to 2022”. Posted via Industry Today. Follow us on Twitter @IndustryToday

2017: Precision medicine moved closer to mainstream

Health systems, researchers, startups, app developers and EHR makers are all taking critical roles in growing the promise of precision medicine.

Future Growth of Bioinformatics Market | Which is Projected to Grow Radiantly By 2022

Market Research Future published a Half-Cooked research report on “Global Bioinformatics Market Research Report - Forecast to 2022” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2022. Posted via Industry Today. Follow us on Twitter @IndustryToday

Illumina Ventures collects $230 mln for maiden fund

San Francisco-based Illumina Ventures, an early-stage venture firm, has raised $230 million for its debut fund. Illumina invests in early-stage companies focused on genomics and precision medicine.

Telegraph Partners and Illumina form Verogen

Telegraph Partners and Illumina Inc have launched San Diego-based Verogen Inc, which will accelerate development of Illumina’s forensic genomics technologies. No financial terms were disclosed. Kirk Malloy will serve as CEO.

Illumina Company Life and Culture

You may also be interested in